Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Andrew Melville"'
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-7 (2024)
Abstract In a cardiac output (CO) sub-study of the Restrictive versus Liberal Fluid Therapy in Major Abdominal Surgery (RELIEF) trial, it was shown that restrictive fluid management was associated with lower cardiac index at the end of surgery. Howev
Externí odkaz:
https://doaj.org/article/50511d3944cc41ff8cb90820bcdb54c2
Publikováno v:
Frontiers in Molecular Biosciences, Vol 7 (2020)
Cardiovascular disease accounts for millions of deaths each year and is currently the leading cause of mortality worldwide. The aging process is clearly linked to cardiovascular disease, however, the exact relationship between aging and heart functio
Externí odkaz:
https://doaj.org/article/dc2ee6487edd43af951ea85a6e437964
Autor:
Marc Lipman, Elisha Pickett, Alison Rodger, Margaret Johnson, James Brown, Christianna Kyriacou, Kelly Edwards, Hemal Joshi, Nafeesah Stewart, Andrew Melville, Jan Flint, Angela Bartley
Publikováno v:
BMJ Open Respiratory Research, Vol 6, Iss 1 (2019)
Introduction People living with HIV (PLWH) are more likely to smoke than the general population and are at greater risk of smoking-related illness. Healthcare services need to address this burden of preventable disease.Methods We evaluated the impact
Externí odkaz:
https://doaj.org/article/6633b855eea547b083b088a2803840b1
Publikováno v:
Frontiers in Medicine, Vol 6 (2019)
The treatment of rheumatoid arthritis (RA) has been transformed with the introduction of biologic disease modifying anti-rheumatic drugs (bDMARD) and more recently, targeted synthetic DMARD (tsDMARD) therapies in the form of janus-kinase inhibitors.
Externí odkaz:
https://doaj.org/article/ca0b57f4014945c89d6d1461d71c76f8
Autor:
Andrew Melville
Publikováno v:
Rheumatology Advances in Practice. 6
Introduction/Background Dactylitis is a hallmark feature of PsA (PsA) and related spondyloarthritides and may affect up to half of PsA patients during the course of their disease(1). Presence of dactylitis may imply a more aggressive disease phenotyp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::208edf35f7b3e314f3db2db5b8267c57
https://doi.org/10.1093/rap/rkac066.012
https://doi.org/10.1093/rap/rkac066.012
Publikováno v:
Fitton, J, Melville, A R, Emery, P, Nam, J L & Buch, M H 2020, ' Real-world single centre use of JAK inhibitors across the rheumatoid arthritis pathway ', Rheumatology . https://doi.org/10.1093/rheumatology/keaa858
Objectives To evaluate real-world efficacy of approved JAK inhibitors (JAKi) tofacitinib and baricitinib in a large, single-centre cohort of RA patients across the treatment pathway, including those refractory to multiple biologic drugs. Methods All
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d59f5f5385ae8694d9b5af2bd4b64999
https://doi.org/10.1093/rheumatology/keaa858
https://doi.org/10.1093/rheumatology/keaa858
Autor:
John Fitton, Andrew Melville
Publikováno v:
Orthopaedics and Trauma. 33:204-211
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::743f0e4360a8e5784042e77dcf9f4a4d
https://doi.org/10.1016/j.mporth.2019.05.001
https://doi.org/10.1016/j.mporth.2019.05.001
Autor:
Benazir Saleem, Lynda Bailey, Shouvik Dass, Paul Emery, Andrew Melville, L. Garcia-Montoya, Maya H Buch, Yuzaiful Md Yusof, John Fitton
Publikováno v:
Rheumatology.
Objective To evaluate the impact of non-medical switch from rituximab originator (RTX-O) to biosimilar (RTX-B) in patients with RA. Methods Between October 2017 and October 2019, all patients on RTX-O in our centre requiring re-treatment were switche
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e750a1d3bf5db071a3d406e66c98c1fd
https://doi.org/10.1093/rheumatology/keaa834
https://doi.org/10.1093/rheumatology/keaa834
Publikováno v:
Rheumatology. 59
Background There has been a national cost-saving drive to switch from originator rituximab (RTX-O) to biosimilar (RTX-B). Whilst regulatory clinical trials necessitate demonstration of equivalence, subtle physicochemical changes could theoretically a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::663869c8769aa93444fa7d439c8e8eb5
https://doi.org/10.1093/rheumatology/keaa111.011
https://doi.org/10.1093/rheumatology/keaa111.011
Publikováno v:
Critical Care Medicine
Supplemental Digital Content is available in the text.
Objectives: To describe the characteristics, circumstances, change over time, resource use, and outcomes of patients admitted to ICUs in Australia and New Zealand for the purposes of “pall
Objectives: To describe the characteristics, circumstances, change over time, resource use, and outcomes of patients admitted to ICUs in Australia and New Zealand for the purposes of “pall
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28fc67c189f6e2c44f515e4c7f0e5b2c
http://europepmc.org/articles/PMC5598912
http://europepmc.org/articles/PMC5598912